🫡 Goodbye, Aduhelm 🫡

Thank you for the journalism awards!

February 2, 2024 Check out STAT+

Sponsored By

What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a singular regulator? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. We explain the debate over Vertex Pharmaceuticals' novel pain drug, whose success in clinical trials comes with a sizable caveat. We also talk about the latest news in the life sciences, including an epitaph for Aduhelm and the retirement of an FDA icon. LISTEN NOW Subscribe to the podcast to never miss an episode iTunes Google Spotify SoundCloud Podcast Addict TuneIn Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser